| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
24,740,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.35 - $0.35 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-18 |
2023-10-17 |
2023-04-18 |
2022-04-18 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Woloshen Daniel S |
Senior VP and General Counsel |
• – – |
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
30,600 |
109,425 |
|
- |
|
| Scotland Richard A |
Senior VP, Regulatory Affairs |
• – – |
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
30,600 |
112,574 |
|
- |
|
| Cox Geoffrey F |
President, CEO and Chairman |
• • – |
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
61,200 |
489,717 |
|
- |
|
| Tuck Alan W |
Director |
– • – |
2008-06-27 |
4 |
A |
$0.40 |
$1,500 |
D/D |
3,731 |
13,141 |
|
- |
|
| Miller Marvin |
Director |
– • – |
2008-06-27 |
4 |
A |
$0.40 |
$1,200 |
D/D |
2,985 |
13,396 |
|
- |
|
| Mcnamara Pamela W |
Director |
– • – |
2008-06-27 |
4 |
A |
$0.40 |
$1,000 |
D/D |
2,488 |
12,983 |
|
- |
|
| Bechon Christian |
Director |
– • • |
2008-06-27 |
4 |
A |
$0.40 |
$5,000 |
D/D |
12,438 |
39,944 |
|
- |
|
| Geraghty James A |
Director |
– • – |
2008-06-27 |
4 |
A |
$0.40 |
$2,750 |
D/D |
6,841 |
98,787 |
|
- |
|
| Bullock Francis J |
Director |
– • – |
2008-06-27 |
4 |
A |
$0.40 |
$1,875 |
D/D |
4,664 |
18,728 |
|
- |
|
| Miller Marvin |
Director |
– • – |
2008-03-28 |
4 |
A |
$0.55 |
$1,200 |
D/D |
2,182 |
10,411 |
|
- |
|
| Mcnamara Pamela W |
Director |
– • – |
2008-03-28 |
4 |
A |
$0.55 |
$1,000 |
D/D |
1,818 |
10,495 |
|
- |
|
| Bechon Christian |
Director |
– • – |
2008-03-28 |
4 |
A |
$0.55 |
$5,000 |
D/D |
9,091 |
27,506 |
|
- |
|
| Tuck Alan W |
Director |
– • – |
2008-03-28 |
4 |
A |
$0.55 |
$1,500 |
D/D |
2,727 |
9,410 |
|
- |
|
| Bullock Francis J |
Director |
– • – |
2008-03-28 |
4 |
A |
$0.55 |
$1,875 |
D/D |
3,409 |
14,064 |
|
- |
|
| Geraghty James A |
Director |
– • – |
2008-03-28 |
4 |
A |
$0.55 |
$2,750 |
D/D |
5,000 |
91,946 |
|
- |
|
| Bechon Christian |
Director |
– • • |
2008-03-25 |
4 |
A |
$0.00 |
$0 |
I/I |
14,500,000 |
20,148,404 |
|
- |
|
| Lfb Biotechnologies S.a.s.u. |
10% Owner |
– – • |
2008-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
14,500,000 |
20,148,404 |
|
- |
|
| Cox Geoffrey F |
President, CEO and Chairman |
• • – |
2008-03-14 |
4 |
B |
$0.46 |
$47,697 |
D/D |
100,400 |
428,517 |
2.81 |
- |
|
| Liposky Gregory F |
Senior VP, Operations |
• – – |
2008-03-12 |
4 |
S |
$0.56 |
$12,926 |
D/D |
(22,930) |
45,336 |
|
- |
|
| Woloshen Daniel S |
Senior VP and General Counsel |
• – – |
2008-03-12 |
4 |
S |
$0.57 |
$9,699 |
D/D |
(17,000) |
78,825 |
|
- |
|
| Scotland Richard A |
Senior VP, Regulatory Affairs |
• – – |
2008-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
27,645 |
81,974 |
|
- |
|
| Meade Harry |
SVP, Transgenic Research |
• – – |
2008-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
34,986 |
134,212 |
|
- |
|
| Green John B |
Senior VP and CFO |
• – – |
2008-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
32,970 |
120,170 |
|
- |
|
| Liposky Gregory F |
Senior VP, Operations |
• – – |
2008-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
33,618 |
68,266 |
|
- |
|
| Cox Geoffrey F |
President, CEO and Chairman |
• • – |
2008-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
73,442 |
328,117 |
|
- |
|
216 Records found
|
|
Page 4 of 9 |
|
|
